Advertisement
U.S. Markets open in 5 hrs 34 mins
S&P Futures
5,906.00 0.00 (0.00%) Dow Futures
43,565.00 +47.00 (+0.11%) Nasdaq Futures
20,458.25 -25.25 (-0.12%) Russell 2000 Futures
2,293.30 +2.10 (+0.09%) Crude Oil
69.66 +0.44 (+0.64%) Gold
2,742.50 +12.50 (+0.46%)
Entheon Biomedical Corp. (ENBI.CN)
Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Follow
At close: 11:48AM EDT
Currency in CAD
Valuation Measures4
| Market Cap (intraday) | 1.24M |
| Enterprise Value | 941.11k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.53 |
| Price/Book (mrq) | 4.22 |
| Enterprise Value/Revenue | 4.88 |
| Enterprise Value/EBITDA | -0.42 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.05 |
| 52-Week Change 3 | N/A |
| S&P500 52-Week Change 3 | N/A |
| 52 Week High 3 | 0.2500 |
| 52 Week Low 3 | 0.0000 |
| 50-Day Moving Average 3 | 0.1079 |
| 200-Day Moving Average 3 | 0.1222 |
Share Statistics
| Avg Vol (3 month) 3 | 17.79k |
| Avg Vol (10 day) 3 | 7.07k |
| Shares Outstanding 5 | 8.86M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 8.57M |
| % Held by Insiders 1 | 2.14% |
| % Held by Institutions 1 | 0.00% |
| Shares Short (Sep 13, 2024) 4 | 573 |
| Short Ratio (Sep 13, 2024) 4 | 0.01 |
| Short % of Float (Sep 13, 2024) 4 | N/A |
| Short % of Shares Outstanding (Sep 13, 2024) 4 | 0.01% |
| Shares Short (prior month Aug 15, 2024) 4 | 200 |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:3 |
| Last Split Date 3 | Nov 12, 2020 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Nov 30, 2023 |
| Most Recent Quarter (mrq) | May 31, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -48.64% |
| Return on Equity (ttm) | -86.71% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 0.00 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -337.8k |
| Diluted EPS (ttm) | -0.0600 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 299.14k |
| Total Cash Per Share (mrq) | 0.03 |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 7.95 |
| Book Value Per Share (mrq) | 0.03 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -351.32k |
| Levered Free Cash Flow (ttm) | -238.74k |
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.